. Author manuscript; available in PMC: 2017 Aug 1.

Published in final edited form as: Ann Surg Oncol. 2016 Mar 28;23(8):2548–2555. doi: 10.1245/s10434-016-5205-4

Table 2. Multivariable Analysis for Association with pCR.

Variables	OR	95% CI	p-value
KRAS (Mutant vs. Wild-type)	0.34	(0.17 - 0.66)	0.002
Clinical Stage (III vs. II)	1.23	(0.58 - 2.60)	0.585
Time from CRT to Surgery (8+ weeks vs. < 8 weeks)	1.70	(0.80 - 3.62)	0.171
Cycles of FOLFOX (3+ vs. < 3)	1.09	(0.58 - 2.07)	0.788